Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: ACTIV

News Roundup | Egypt Ivermectin-based Study Results Are In

Story 1: Mansoura University Ivermectin-based Study Results in Superior Viral Clearance & Peer Review Status in Journal of Medical Virology: […]

1 week ago
Share

University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial

Although COVID-19 vaccines are now available for emergency use, that doesn’t preclude the desperate need for compelling, effective and safe […]

University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial
2 weeks ago
Share

Rural St. Lawrence Health Care System Participates Heavily in NIH-Sponsored COVID-19 Research Programs

Rural health systems can at times have less access to advanced clinical trials than do urban systems centering on prominent […]

Rural St. Lawrence Health Care System Participates Heavily in NIH-Sponsored COVID-19 Research Programs
2 weeks ago
Share

China & RTP’s Brii Biosciences Selected by NIAID for Combo Monoclonal Antibody Clinical Trial Targeting COVID-19

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), continues to invest […]

China & RTP’s Brii Biosciences Selected by NIAID for Combo Monoclonal Antibody Clinical Trial Targeting COVID-19
4 weeks ago
Share

Real-World Factors Continue to Hamper Distribution and Use of Monoclonal Antibody Treatments During COVID-19 Pandemic

A recent account indicates a successful treatment involving Eli Lilly’s monoclonal antibody treatment for COVID-19, known as bamlanivimab. After receiving […]

Real-World Factors Continue to Hamper Distribution and Use of Monoclonal Antibody Treatments During COVID-19 Pandemic
2 months ago
Share

NIH’s Therapeutic Management of Patients with COVID-19 & Some Unanswered Questions About Disturbing Chasm

The National Institutes of Health (NIH) recently updated the COVID-19 Treatment Guidelines: Therapeutic Management of Patients with COVID-19 guidelines highlighting […]

NIH’s Therapeutic Management of Patients with COVID-19 & Some Unanswered Questions About Disturbing Chasm
3 months ago
Share

WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19

Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National […]

WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19
5 months ago
Share

Is NIAID Exploring Human Challenge Studies as an Alternative or Complement to Large Clinical Trials?

A number of media recently reported that the National Institutes of Allergy and Infectious Diseases (NIAID) communicated that government scientists […]

Is NIAID Exploring Human Challenge Studies as an Alternative or Complement to Large Clinical Trials?
7 months ago
Share

ACTIV: Centralization an Important Part of COVID-19 Fight, But Smaller Players and Community Left Out

With the COVID-19 pandemic raging, the National Institutes of Health (NIH) announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) […]

ACTIV Centralization an Important Part of COVID-19 Fight, But Smaller Players and Community Left Out
7 months ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.